Viewing StudyNCT02947685



Ignite Creation Date: 2024-05-06 @ 9:17 AM
Last Modification Date: 2024-10-26 @ 12:12 PM
Study NCT ID: NCT02947685
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-17
First Post: 2016-10-26

Brief Title: Randomized Open Label Clinical Study of the Targeted Therapy Palbociclib to Treat Metastatic Breast Cancer
Sponsor: Alliance Foundation Trials LLC
Organization: Alliance Foundation Trials LLC

Organization Data

Organization: Alliance Foundation Trials LLC
Class: OTHER
Study ID: AFT-38
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Alliance Foundation Trials LLC
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Pfizer INDUSTRY
German Breast Group OTHER
Fondazione Michelangelo OTHER
PrECOG LLC OTHER
Breast Cancer Trials Australia and New Zealand OTHER
Syneos Health OTHER
SOLTI Breast Cancer Research Group OTHER
UNICANCER OTHER